Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Globionic
San Francisco, California, United Statesglobionic.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Globionic is a biotechnology company focused on the discovery and development of novel therapeutics targeting G protein-coupled receptors (GPCRs). The company leverages a proprietary platform to identify and optimize small molecules and peptides that can modulate GPCR activity with high specificity. Their primary research focus is on metabolic disorders, including obesity and type 2 diabetes, as well as inflammatory conditions. By utilizing advanced structural biology and computational screening, Globionic aims to address unmet medical needs in chronic disease management. The company is currently in the pre-clinical stage, advancing several internal programs toward candidate selection.
- Therapeutic areas
- EndocrinologyImmunologyMetabolic Disorders
- Modalities
- Small moleculePeptides
- Industry
- Biotech
Beyond the preview
Go deeper on Globionic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Globionic.